ReviewFrontiers in oncology2017

Current Advances in Checkpoint Inhibitors: Lessons from Non-Central Nervous System Cancers and Potential for Glioblastoma.

Natasha Lakin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.